VarCov Co’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
VarCov Co's NVAX Position: Q3 2026 in Review
VarCov Co sold out of Novavax (NVAX) in Q3 2026, closing a stake of 29,403 shares — an estimated $277K sold.
VarCov Co first reported a position in NVAX in Q4 2025 and held it in 3 quarters. The position peaked at $277K in Q2 2026. 262 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.
- VarCov Co reported no remaining Novavax position as of Q3 2026 after selling out during the quarter.
- VarCov Co sold 29,403 Novavax shares in Q3 2026, an estimated $277K.
- VarCov Co first reported a position in Novavax in Q4 2025 and held it in 3 quarters.
- VarCov Co's Novavax position peaked at $277K in Q2 2026.
- 262 funds tracked by Wall St. Rank held Novavax as of Q3 2026.
Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.